Additional file 2. HAE Lower Quality Comparison Study Evidence Tables. Lower Quality Comparison Studies. Includes data extraction, quality assessments, and study reference codes and citations for lowe
Hereditary Angioedema Market is valued at USD 2.86 Bn in 2024, is anticipated to reaching USD 5.36 Bn by 2031, with a steady annual growth rate of 9.4%.
We performed a metagenome-wide association study on fecal samples from 74 CRC patients and 54 controls from China and validated the results in 16 patients and 24 controls from Denmark. We further vali
Background: No published data presently exist concerning hereditary angioedema (HAE) in Turkey. The aim of the study was to initiate a preliminary multicentric evaluation about HAE and to deter